REVOLUTION MEDICINES INC's ticker is RVMD and the CUSIP is 76155X100. A total of 135 filers reported holding REVOLUTION MEDICINES INC in Q4 2022. The put-call ratio across all filers is 0.32 and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $33,822,018 | +20.8% | 1,419,900 | 0.0% | 14.38% | -12.1% |
| Q3 2022 | $28,000,000 | +1.2% | 1,419,900 | 0.0% | 16.36% | -10.1% |
| Q2 2022 | $27,674,000 | -23.6% | 1,419,900 | 0.0% | 18.20% | +37.1% |
| Q1 2022 | $36,222,000 | +1.4% | 1,419,900 | 0.0% | 13.27% | +29.1% |
| Q4 2021 | $35,739,000 | -8.5% | 1,419,900 | 0.0% | 10.28% | +16.0% |
| Q3 2021 | $39,061,000 | -13.3% | 1,419,900 | 0.0% | 8.86% | -58.7% |
| Q2 2021 | $45,068,000 | -30.8% | 1,419,900 | 0.0% | 21.46% | -10.6% |
| Q1 2021 | $65,145,000 | +15.9% | 1,419,900 | 0.0% | 24.00% | +33.1% |
| Q4 2020 | $56,214,000 | +13.8% | 1,419,900 | 0.0% | 18.03% | +6.0% |
| Q3 2020 | $49,413,000 | +10.2% | 1,419,900 | 0.0% | 17.01% | -17.6% |
| Q2 2020 | $44,826,000 | +44.1% | 1,419,900 | 0.0% | 20.65% | -27.4% |
| Q1 2020 | $31,110,000 | – | 1,419,900 | – | 28.44% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Nextech Invest Ltd. | 4,839,529 | $104,824,198 | 43.76% |
| Column Group LLC | 4,577,840 | $99,156,014 | 35.85% |
| Mass General Brigham, Inc | 338,191 | $7,325 | 5.71% |
| Boxer Capital, LLC | 4,684,264 | $101,461 | 4.98% |
| BVF INC/IL | 4,955,588 | $107,338,036 | 3.92% |
| DAFNA Capital Management LLC | 575,785 | $12,471,503 | 3.74% |
| EcoR1 Capital, LLC | 5,352,183 | $115,928,284 | 3.73% |
| Casdin Capital, LLC | 1,810,000 | $39,204,600 | 3.23% |
| Artal Group S.A. | 2,070,988 | $44,858 | 2.66% |
| Integral Health Asset Management, LLC | 345,000 | $7,472,700 | 1.50% |